Covariates: age, gender, number of colonoscopies, history of polyps prior to baseline, aspirin use, dietary fiber, and total vitamin D intake

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases (Event)* No. of Non-cases N** Mean Follow-up, mo Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI** P between groups*** P for trend****
12020102 Martinez 2002 Adenoma recurrence 1 st total calcium intake quartile (mg/day) < 778 178 148 36.8 adjusted OR 1.00 0.004
Adenoma recurrence 2 nd total calcium intake quartile (mg/day) 778–996 175 151 36.8 adjusted OR 0.92 0.65, 1.29 nd
Adenoma recurrence 3 rd total calcium intake quartile (mg/day) 997–1279 148 178 36.8 adjusted OR 0.66 0.47, 0.94 nd
Adenoma recurrence 4 th total calcium intake quartile (mg/day) >1279 138 188 36.8 adjusted OR 0.62 0.42, 0.90 nd

From: Appendix C, Evidence Tables: L-Q

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.